123 related articles for article (PubMed ID: 22889825)
1. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
[TBL] [Abstract][Full Text] [Related]
2. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
3. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
Burkin MA; Sviridov VV; Perelygina OV
Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody.
Yu S; Gu J; Wang HG; Wang QX; Luo P; Wu C; Zhang WJ; Guo G; Tong WD; Zou QM; Mao XH
Clin Immunol; 2011 Jan; 138(1):77-84. PubMed ID: 21075691
[TBL] [Abstract][Full Text] [Related]
5. Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice.
Zhang G; Yu R; Chi X; Chen Z; Hao M; Du P; Fan P; Liu Y; Dong Y; Fang T; Chen Y; Song X; Liu S; Li J; Yu C; Chen W
Int Immunopharmacol; 2021 Feb; 91():107297. PubMed ID: 33360088
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin.
Lang AB; Cryz SJ; Schürch U; Ganss MT; Bruderer U
J Immunol; 1993 Jul; 151(1):466-72. PubMed ID: 8326138
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
8. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
9. A single human monoclonal antibody that confers total protection from tetanus.
Arunachalam B; Ghosh S; Talwar GP; Raghupathy R
Hybridoma; 1992 Apr; 11(2):165-79. PubMed ID: 1376715
[TBL] [Abstract][Full Text] [Related]
10. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.
Tierney R; Nakai T; Parkins CJ; Caposio P; Fairweather NF; Sesardic D; Jarvis MA
Vaccine; 2012 Apr; 30(20):3047-52. PubMed ID: 22414558
[TBL] [Abstract][Full Text] [Related]
11. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
[TBL] [Abstract][Full Text] [Related]
14. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
15. Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis.
Jarząb A; Witkowska D; Ziomek E; Setner B; Czajkowska A; Dorot M; Szewczuk Z; Gamian A
Vaccine; 2018 Jul; 36(31):4641-4649. PubMed ID: 29960802
[TBL] [Abstract][Full Text] [Related]
16. Protective murine monoclonal antibodies to tetanus toxin.
Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
[TBL] [Abstract][Full Text] [Related]
17. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
Simpson LL; Lake P; Kozaki S
J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
